Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.

Wang, Xiaodong; Qian, Jing; Yao, Ninghua; Pocha, Christine; Kang, Koo Jeong; Angelico, Roberta; Zhu, Guodong.

Afiliação

Wang X; Department of Interventional, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Qian J; Department of Cancer Center, Affiliated Hospital of Nantong University, Nantong, China.
Yao N; Department of Cancer Center, Affiliated Hospital of Nantong University, Nantong, China.
Pocha C; Avera McKennnan Hospital and University Medical Center, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
Kang KJ; Department of Surgery, Keimyung University School of Medicine, Dongsan Medical Center, Daegu, Republic of Korea.
Angelico R; HPB and Transplant Unit, Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.
Zhu G; Department of Hepatobiliary Surgery, Affiliated Nantong Hospital 3 of Nantong University, Nantong, China.

Ann Transl Med ; 10(10): 595, 2022 May.

Article em En | MEDLINE | ID: mdl-35722420

Palavras-chave

Hepatocellular carcinoma (HCC); The Cancer Genome Atlas (TCGA); cancer-related metabolic reprogramming; long non-coding RNA (lncRNA); tumor immune microenvironment (TIME)

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article